Sitagliptin Metformin Tablets work by lowering blood sugar and are used to treat type 2 diabetes. Side effects include gastrointestinal reactions, allergies, acute pancreatitis, and worsening of kidney function. It is recommended to take the medication under medical supervision. Sitagliptin Metformin Tablet is a compound preparation whose components are Sitagliptin Phosphate and Metformin Hydrochloride. It is used in conjunction with diet and exercise therapy for patients with type 2 diabetes mellitus whose blood glucose remains poorly controlled by metformin monotherapy or who are receiving a combination of the two. Adverse reactions to this product include gastrointestinal reactions such as nausea, vomiting, bloating and diarrhea, allergic reactions, acute pancreatitis, worsening of renal function, upper respiratory tract infections, headache, and myalgia. Contraindications to this product include nephropathy or abnormal renal function, i.e., serum creatinine level ≥1.5 mg/dl (males), ≥1.4 mg/dl (females), or abnormal creatinine clearance; hypersensitivity to Sitagliptin Phosphate, Metformin Hydrochloride, or any other ingredient in this product; acute or chronic metabolic acidosis, including diabetic ketoacidosis. Sitagliptin metformin tablets should be taken under medical supervision and should not be taken on its own to avoid serious adverse reactions.